RadNet stock, healthcare

RadNet stock trades at EUR 7.68 after Q2 revenue growth

Published on 09/30/2026 at 22:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RadNet posted USD 622.72 million in Q2 revenue and adjusted EPS of USD 0.29. Raymond James set a USD 95.00 target on September 28, 2026.

RadNet stock,  healthcare,  diagnostic imaging,  Q2 2026 results,  analyst coverage,  NASDAQ, Illustration mit AI erstellt.
RadNet stock, healthcare, diagnostic imaging, Q2 2026 results, analyst coverage, NASDAQ, Illustration mit AI erstellt.

RadNet stock was trading at EUR 7.68 at Lang & Schwarz on September 30, 2026 at 10:24 p.m. CEST, down 0.90 percent versus the prior close of EUR 7.75. The latest analyst action came from Raymond James, which initiated coverage with a Strong Buy rating and a USD 95.00 price target on September 28, 2026, according to Investing.com.

Q2 revenue grew 25.0 percent

RadNet's second-quarter 2026 revenue reached USD 622.72 million, compared with an analyst estimate of USD 610.87 million and USD 498.23 million in the prior-year quarter. The figures reported by MarketBeat show a 25.0 percent year-over-year increase and a revenue beat of USD 11.85 million.

Adjusted earnings per share came in at USD 0.29 versus USD 0.20 consensus, a USD 0.09 difference. RadNet also reported record adjusted EBITDA of USD 99.70 million, up 22.7 percent from the prior year, while Digital Health revenue increased 56.5 percent to USD 32.43 million, according to Investing.com.

Raymond James sets USD 95.00 target

Raymond James cited RadNet's imaging growth and the optionality of its digital health business when assigning the USD 95.00 target. The target sits within the broader range of USD 79.00 to USD 105.00 reported for current analyst estimates, while the same coverage noted that digital health spending continues to weigh on margins.

The operating picture therefore has two distinct sides. Revenue and adjusted EBITDA are expanding at double-digit rates, but the digital health segment is still absorbing investment as RadNet builds its software and artificial intelligence offering.

Next results are due November 11

Investing.com lists November 11, 2026 as RadNet's next earnings date. That report will give investors the next comparison point for revenue growth, adjusted EBITDA and the pace of Digital Health expansion.

RadNet stock stays below its yearly high

On Nasdaq, RDNT was last at USD 68.94 on September 30, 2026 at 4:00 p.m. ET, versus USD 70.65 at the prior close. The stock's USD 50.82 to USD 85.84 52-week range places the latest Nasdaq level below its yearly high, while the Lang & Schwarz reference price remained EUR 7.68 in after-hours trading.

RadNet at a glance

  • Company: RadNet, Inc.
  • Ticker: RDNT
  • Primary exchange: NASDAQ
  • Price Lang & Schwarz as of September 30, 2026, 10:24 p.m. CEST: EUR 7.68
  • Change versus prior close: minus 0.90 percent
  • Prior close Lang & Schwarz September 30, 2026: EUR 7.75
  • Market capitalization: USD 5.4 billion (as of September 30, 2026)
  • 52-week range: USD 50.82-85.84 (as of September 30, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research
  • Next earnings date: November 11, 2026

Disclaimer...

en | boerse | 70206557 |